CAS: 1337531-36-8 - GSK2606414
Formula:C24H20F3N5O
InChI:InChI=1S/C24H20F3N5O/c1-31-12-18(21-22(28)29-13-30-23(21)31)15-5-6-19-16(11-15)7-8-32(19)20(33)10-14-3-2-4-17(9-14)24(25,26)27/h2-6,9,11-13H,7-8,10H2,1H3,(H2,28,29,30)
InChI key:InChIKey=SIXVRXARNAVBTC-UHFFFAOYSA-N
SMILES:O=C(N1C=2C=CC(=CC2CC1)C3=CN(C=4N=CN=C(N)C43)C)CC5=CC=CC(=C5)C(F)(F)F
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine
CAS:1337531-36-8
Formula:
C24H20F3N5O
Purity:
99%
Color and Shape:
Solid
Molecular weight:
451.4437
Ref: AN-AG009CC2
5mg | 53.00 € | |
25mg | 122.00 € | |
100mg | 273.00 € |
Estimated delivery in United States, on Monday 6 May 2024
GSK2606414
CAS:1337531-36-8
GSK2606414 is an oral-available and specific PERK inhibitor (IC50=0.4 nM).
Formula:
C24H20F3N5O
Purity:
100%
Color and Shape:
Solid
Molecular weight:
451.44
Ref: TM-T2614
2mg | 66.00 € | |
5mg | 92.00 € | |
10mg | 124.00 € | |
50mg | 324.00 € | |
1ml*10 (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Ref: 7W-GE1408
1mg | 241.00 € | |
5mg | 406.00 € | |
10mg | 619.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Ref: 3D-FG65036
10mg | 186.00 € | |
50mg | 490.00 € |
Estimated delivery in United States, on Friday 17 May 2024
GSK 2606414
CAS:1337531-36-8
Applications GSK 2606414 acts as a potent and selective inhibitor of protein kinase R and …
Formula:
C24H20F3N5O
Color and Shape:
Off-White to Pale Yellow Solid
Molecular weight:
451.44
Ref: TR-G797510
5mg | 165.00 € | |
10mg | 285.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
GSK 2606414-d3
CAS:1337531-36-8
Formula:
C24H19D3F3N5O
Color and Shape:
White to Pale Beige Solid
Molecular weight:
456.478
Ref: TR-G797512
100mg | 24,888.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024